Emergent Transjugular Intrahepatic Portosystemic Shunt Creation for Acute Gastric Variceal Bleeding in Patients with Hepatocellular Carcinoma
Emergent Transjugular Intrahepatic Portosystemic Shunt Creation for Acute Gastric Variceal Bleeding in Patients with Hepatocellular Carcinoma
复制标题
紧急经颈静脉肝内门体分流术治疗肝细胞癌患者急性胃静脉曲张出血
DOI：
10.1016/j.jvir.2022.03.012
复制
发表时间：
2022
影响因子：
2.9
通讯作者：
Xiao Li
中科院分区：
文献类型：
--
作者：
Xiaowu Zhang;Jiaywei Tsauo;Jun Tie;Hui Xue;Jian-Bo Zhao;Jian-Jun Li;Zhu-Ting Fang;Wu-Hua Guo;Xiao Li
共有42名肝硬化患者（平均年龄，51.7岁±10.8; 38名男性）患有肝细胞癌，他们接受了急性植物内植物的portostosytostystystys分流（TIPS），用于控制急性胃静脉曲张的毒气量这些，37名（88.1％）的患者作为控制急性GVB的一线治疗。在40名（95.2％）的患者中，新兴的内窥镜治疗和药物疗法的急性GVB作为急性GVB随访时间为16.9个月（范围为0.1-100.8个月）。 （19.0％）随访期间有18名（42.9％）的患者在随访期间发生了分流功能障碍。向上。
A total of 42 cirrhotic patients (mean age, 51.7 years ± 10.8; 38 men) with hepatocellular carcinoma who underwent emergent transjugular intrahepatic portosystemic shunt (TIPS) creation for controlling acute gastric variceal bleeding (GVB) were included in this multicenter retrospective study. Of these, 37 (88.1%) patients underwent emergent TIPS creation as the first-line treatment to control acute GVB. Five (11.9%) patients underwent emergent TIPS creation as a rescue/salvage treatment to control acute GVB after emergent endoscopic therapy and pharmacotherapy. Emergent TIPS creation was technically successful in 40 (95.2%) patients. Two (4.8%) patients had severe and moderate procedural adverse events. The median follow-up duration was 16.9 months (range, 0.1-100.8 months). Failure to control acute bleeding and failure to prevent rebleeding occurred in 8 (19.0%) patients during follow-up. Eighteen (42.9%) patients died during follow-up. Three (7.1%) patients had shunt dysfunction during follow-up. Overt hepatic encephalopathy occurred in 6 (14.3%) patients during follow-up.